OOIR: Observatory of International Research

Papers

(The median citation count of BMJ Evidence-Based Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
High-value care education can learn from the evidence-based medicine movement: moving beyond competencies and curricula to culture	96
Proposed framework for unifying disease definitions in guideline development	86
Challenges to delivering evidence-based management for long COVID	79
Development of a generalised tool for evaluating success of clinical practice guidelines implementation (A-GIST)	69
Rapid reviews methods series: assessing the appropriateness of conducting a rapid review	67
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps	50
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review	42
How to best convey continuous outcomes in patient decision aids	38
Gender and geographical bias in the editorial decision-making process of biomedical journals: a case-control study	36
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?	35
Associations between device-measured and self-reported physical activity and common mental disorders: Findings from a large-scale prospective cohort study	34
Global considerations for informed consent with shared decision-making in the digital age	33
Making sustainable healthcare decisions: three turns towards sustainable guidelines	32
Measuring progress in institutionalising evidence-informed priority-setting in the Indian healthcare system: an application using the iProSE scale	28
Deceptive shifts in cancer stage distribution	27
Deaths attributed to the use of medications purchased online	26
Acupuncture for acute migraine attacks in adults: a systematic review and meta-analysis	23
Leading with options or issues to support purposeful shared decision-making in clinical practice	23
Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study	23
Exploring the diverse definitions of ‘evidence’: a scoping review	22
Genetic predisposition, modifiable lifestyles, and their joint effects on human lifespan: evidence from multiple cohort studies	21
Assessing proposals to update established screening strategies	21
Ambiguity in care delivery terminology: implications that affect pragmatic clinical trials using non-pharmacological interventions	21
iHealthFacts: a health fact-checking website for the public	20
Dynamic intervention strategies await inclusion in clinical evidence synthesis	20

Evidence-based medicine has already adapted and is very much alive	19
Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India	19
An opportunity for evidence-based care of individuals with monkeypox	18
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines	17
Is a one-size-fits-all ‘12-month rule’ appropriate when it comes to the last search date in systematic reviews?	16
Challenges in the selection and measurement of outcomes in psychiatric trials	16
Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment	14
Catalogue of bias: novelty bias	14
Using a journal club to navigate a maze of COVID-19 papers in a front-line hospital service	14
Piloting a new method to estimate action thresholds in medicine through intuitive weighing	14
Survey of US physicians’ attitudes and knowledge of AI	12
Overcoming challenges in the implementation of clinical practice guidelines in China	12
Interventions for Menière’s disease: an umbrella systematic review	11
Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method	11
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	11
Improving peer review of systematic reviews and related review types by involving librarians and information specialists as methodological peer reviewers: a randomised controlled trial	11
Rapid reviews methods series: Guidance on assessing the certainty of evidence	11
De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis	11
Development of the Reporting Infographics and Visual Abstracts of Comparative studies (RIVA-C) checklist and guide	11
Time deficiency: an affliction of healthcare systems and how to ameliorate it	10
How to interpret studies using Mendelian randomisation	10
Correspondence on “How methodological pitfalls have created widespread misunderstanding about long COVID” by Høeget al	10
Rapid Reviews Methods Series: Involving patient and public partners, healthcare providers and policymakers as knowledge users	10
Enhancing the transparency of clinical practice guidelines by prospective registration: the PREPARE platform	10
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study)	10
Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis	10
Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study	9
Adherence to the Guideline for Reporting Evidence-based practice Educational interventions and Teaching (GREET) of studies on evidence-based healthcare e-learning: a cross-sectional study	9
Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis	9
Consistency between trials presented at conferences, their subsequent publications and press releases	9
Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data	9
Likelihood ratio interpretation of the relative risk	9
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications	8
Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting	8
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation	8
Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study	8
AI in healthcare: an introduction for clinicians	8
Responsible dissemination of health and medical research: some guidance points	8
Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines	8
Retrieval barriers in individual participant data reviews with network meta-analysis	8
Component network meta-analysis in a nutshell	8
Problem-based shared decision-making in diabetes care: a secondary analysis of video-recorded encounters	8
Best way not to misuse p values is not to draw definitive conclusions about hypotheses	8
Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis	7
Preventing overdiagnosis and overuse: proposed guidance for guideline panels	7
Revisiting the value of Archie Cochrane’s contributions	7
Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review	7
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic	7
Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial	6
Reducing the environmental impact of healthcare to improve health, sustainability and equity	6

Overly complex methods may impair pragmatic use of core evidence-based medicine principles	6
Identifying and counteracting fraudulent responses in online recruitment for health research: a scoping review	6
Using individual participant data to improve network meta-analysis projects	6
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic	5
Toward automating GRADE classification: a proof-of-concept evaluation of an artificial intelligence-based tool for semiautomated evidence quality rating in systematic reviews	5
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank	5
Integrating large language models in systematic reviews: a framework and case study using ROBINS-I for risk of bias assessment	5
Education in evidence-based health care: never a greater need	5
Incomplete reporting and spin in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study	5
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health	5
Twenty-one years of the International Shared Decision Making Conference: lessons learnt and future priorities	5
Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent	5
Developing future leaders in evidence-based medicine: the inaugural David Sackett Fellowship	5
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis	5
Rapid reviews methods series: Guidance on literature search	5
Enhancing title and abstract screening for systematic reviews with GPT-3.5 turbo	5
The path of Chile towards the institutionalisation of evidence-based health policy	5
Integrating a climate lens into the design of education programmes for health professionals	5
Quality of reporting among systematic reviews underpinning the ESC/ACC guidelines on ventricular arrhythmias and sudden cardiac death	4
Identifying actionable statements in Chinese health guidelines: a cross-sectional study	4
Aducanumab for Alzheimer’s disease: expediting approval and delaying science	4
Interpreting the results from the first randomised controlled trial of colonoscopy: does it save lives?	4
Data-dredging bias	4
Attitudes of people living with cancer towards trial non-publication and research participation	4
Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis	4
Ten resources for understanding bias in health research: EBM live workshop 2022	4
Context matters! What is really tested in an RCT?	4
Correspondence on ‘The limits of shared decision making’ by Elwynet al: We call for a more nuanced approach	4
Theory and practice of Bayesian and frequentist frameworks for network meta-analysis	4
Reporting of patient-reported outcomes in trials on alcohol use disorder: a meta-epidemiological study	4
Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension	4
In-person schooling is essential even during periods of high transmission of COVID-19	4
Meta-analysis of continuous outcomes: a user’s guide for analysis and interpretation	4
Smartphone apps for point-of-care information summaries: systematic assessment of the quality and content	3
Registration of health and medical research	3
Does the format of result presentation and type of conclusion in Cochrane plain language summaries matter? A randomised controlled trial	3
Insights on the German College of General Practitioners and Family Physicians (DEGAM) guideline addressing medical overuse	3
Innovating in healthcare: perspective from a dual role	3
When does the placebo effect have an impact on network meta-analysis results?	3
Thresholds for interpreting the fragility index derived from sample of randomised controlled trials in cardiology: a meta-epidemiologic study	3
Different meta-analysis methods can change judgements about imprecision of effect estimates: a meta-epidemiological study	3
When we move cancer drugs from the second or third to the first line of treatment: what lessons can we learn from KEYNOTE-177 and JAVELIN-100	3
Teaching evidence-based medicine by using a systematic review framework: implementation in a Swedish university setting	3
Rapid review method series: interim guidance for the reporting of rapid reviews	3
Health technology assessment in India in the next decade: reflections on a vision for its path to maturity and impact	3
Non-pharmacological interventions for autism spectrum disorder in children: an overview of systematic reviews	3
Efforts towards the institutionalisation of evidence-informed decision-making	3
Advancing evidence-based medicine in China: an interview with Gordon Guyatt	3
Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology	3
Guest authorship as research misconduct: definitions and possible solutions	3
Applying the time needed to treat to NICE guidelines on lifestyle interventions	3
All health is not equal: the use of modifiers in NICE technology appraisal	3
Enhanced access but increased testing with virtual care: insights from a multinational survey	3
Methylphenidate denied access to the WHO List of Essential Medicines for the second time	3
Re-evaluating the role of pilot trials in informing effect and sample size estimates for full-scale trials: a meta-epidemiological study	2
Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses	2
Patient-reported effects of hospital-wide implementation of shared decision-making at a university medical centre in Germany: a pre–post trial	2
Reducing low value care: opportunities and challenges for Choosing Wisely campaigns	2
What makes a ‘good’ decision with artificial intelligence? A grounded theory study in paediatric care	2
Implementing AI models in clinical workflows: a roadmap	2
Should COVID-19 vaccination be mandatory?	2
The Six Steps of SDM: linking theory to practice, measurement and implementation	2
Rapid reviews methods series: guidance on rapid scoping, mapping and evidence and gap map (‘Big Picture Reviews’)	2
Transparency of COVID-19 vaccine trials: decisions without data	2
Use of digital patient decision-support tools for atrial fibrillation treatments: a systematic review and meta-analysis	2
Teaching evidence-based medicine in Mexico: a systematic review of medical doctor curriculums at a national level	2
Shared decision-making as a method of care	2
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges	2
Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal	2
Reporting health and medical research	2
Pharmacological interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units: a network meta-analysis	2
Advocating for evidence-informed decisions to make healthcare fit for each person	2
Towards transparency: adoption of WHO best practices in clinical trial registration and reporting among top medical research funders in the USA	2
From promise to practice: challenges and pitfalls in the evaluation of large language models for data extraction in evidence synthesis	2
Bias, quality and reporting in health research: differences and tools for appraisal	2
Rapid review methods series: Guidance on the use of supportive software	2
Kidney trajectory charts to assist general practitioners in the assessment of patients with reduced kidney function: a randomised vignette study	2